Sk Life Science, Inc.

This study is testing whether cenobamate (brand name Xcopri) is safe and effective for children aged 2-17 who have partial-onset (focal) seizures. Researchers will give the medication to 140 children who are already taking 1-3 other seizure drugs to see if it helps reduce seizure…